By Stephen Nakrosis
Elanco Animal Health Inc. (ELAN) said it received a second request for information from the U.S. Federal Trade Commission regarding its planned acquisition of Bayer AG's animal health business.
In August, the two companies announced a deal that will see Elanco acquire the unit in a cash-and-stock deal valued at $7.6 billion. At the time, the companies said the transaction was expected to close by the middle of next year.
Elanco said Monday, "The request was anticipated as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and the review continues to progress as expected."
--Write to Stephen Nakrosis at firstname.lastname@example.org